nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—CYP3A4—bone cancer	0.601	1	CbGaD
Voriconazole—CYP2B6—Cisplatin—bone cancer	0.0152	0.416	CbGbCtD
Voriconazole—CYP2B6—Doxorubicin—bone cancer	0.0102	0.279	CbGbCtD
Voriconazole—CYP2C9—Cisplatin—bone cancer	0.00804	0.22	CbGbCtD
Voriconazole—Fluconazole—CYP3A4—bone cancer	0.00511	1	CrCbGaD
Voriconazole—FMO1—Tamoxifen metabolism—CYP3A4—bone cancer	0.00336	0.0565	CbGpPWpGaD
Voriconazole—CYP3A4—Doxorubicin—bone cancer	0.00313	0.0856	CbGbCtD
Voriconazole—FMO1—Metapathway biotransformation—CYP4V2—bone cancer	0.00311	0.0524	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—FEV—bone cancer	0.00244	0.0411	CbGpPWpGaD
Voriconazole—FMO3—Tamoxifen metabolism—CYP3A4—bone cancer	0.0024	0.0404	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—CYP4V2—bone cancer	0.00223	0.0375	CbGpPWpGaD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00209	0.0352	CbGpPWpGaD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00155	0.0261	CbGpPWpGaD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00151	0.0255	CbGpPWpGaD
Voriconazole—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.0013	0.0219	CbGpPWpGaD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00118	0.0198	CbGpPWpGaD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00117	0.0197	CbGpPWpGaD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00107	0.018	CbGpPWpGaD
Voriconazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00102	0.0172	CbGpPWpGaD
Voriconazole—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.00101	0.017	CbGpPWpGaD
Voriconazole—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000972	0.0163	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000901	0.0152	CbGpPWpGaD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00084	0.0141	CbGpPWpGaD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000837	0.0141	CbGpPWpGaD
Voriconazole—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000761	0.0128	CbGpPWpGaD
Voriconazole—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000747	0.0126	CbGpPWpGaD
Voriconazole—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.00073	0.0123	CbGpPWpGaD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000704	0.0118	CbGpPWpGaD
Voriconazole—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000703	0.0118	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000666	0.0112	CbGpPWpGaD
Voriconazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000662	0.0111	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000651	0.011	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—CYP3A4—bone cancer	0.000624	0.0105	CbGpPWpGaD
Voriconazole—FMO1—Metapathway biotransformation—CYP3A4—bone cancer	0.000616	0.0104	CbGpPWpGaD
Voriconazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.000577	0.00971	CbGpPWpGaD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000577	0.0097	CbGpPWpGaD
Voriconazole—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000565	0.0095	CbGpPWpGaD
Voriconazole—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000543	0.00914	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—GSTP1—bone cancer	0.000534	0.00899	CbGpPWpGaD
Voriconazole—FMO1—Metapathway biotransformation—GSTP1—bone cancer	0.000527	0.00886	CbGpPWpGaD
Voriconazole—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000515	0.00866	CbGpPWpGaD
Voriconazole—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000513	0.00863	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000504	0.00847	CbGpPWpGaD
Voriconazole—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000502	0.00844	CbGpPWpGaD
Voriconazole—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000495	0.00833	CbGpPWpGaD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000489	0.00822	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000459	0.00773	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000452	0.00761	CbGpPWpGaD
Voriconazole—FMO3—Biological oxidations—CYP3A4—bone cancer	0.000446	0.00751	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—CYP3A4—bone cancer	0.00044	0.00741	CbGpPWpGaD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00042	0.00706	CbGpPWpGaD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000414	0.00697	CbGpPWpGaD
Voriconazole—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000388	0.00652	CbGpPWpGaD
Voriconazole—FMO3—Biological oxidations—GSTP1—bone cancer	0.000382	0.00642	CbGpPWpGaD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00038	0.0064	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—GSTP1—bone cancer	0.000377	0.00634	CbGpPWpGaD
Voriconazole—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.000375	0.00631	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—NDUFA12—bone cancer	0.000374	0.0063	CbGpPWpGaD
Voriconazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000354	0.00595	CbGpPWpGaD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00034	0.00572	CbGpPWpGaD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000337	0.00567	CbGpPWpGaD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00033	0.00555	CbGpPWpGaD
Voriconazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000314	0.00528	CbGpPWpGaD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00031	0.00522	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—NT5C3A—bone cancer	0.00031	0.00522	CbGpPWpGaD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000306	0.00515	CbGpPWpGaD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000303	0.0051	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000303	0.0051	CbGpPWpGaD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000299	0.00504	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—NDUFA12—bone cancer	0.000268	0.0045	CbGpPWpGaD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000252	0.00423	CbGpPWpGaD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000246	0.00414	CbGpPWpGaD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000235	0.00395	CbGpPWpGaD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000231	0.00389	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—NT5C3A—bone cancer	0.000222	0.00373	CbGpPWpGaD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000214	0.0036	CbGpPWpGaD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000211	0.00355	CbGpPWpGaD
Voriconazole—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000209	0.00351	CbGpPWpGaD
Voriconazole—Visual impairment—Methotrexate—bone cancer	0.000201	0.000675	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.0002	0.00067	CcSEcCtD
Voriconazole—Hypersensitivity—Cisplatin—bone cancer	0.000199	0.000669	CcSEcCtD
Voriconazole—Bradycardia—Epirubicin—bone cancer	0.000199	0.000668	CcSEcCtD
Voriconazole—Erythema multiforme—Methotrexate—bone cancer	0.000197	0.000663	CcSEcCtD
Voriconazole—Neuropathy peripheral—Doxorubicin—bone cancer	0.000197	0.000663	CcSEcCtD
Voriconazole—Stomatitis—Doxorubicin—bone cancer	0.000196	0.000659	CcSEcCtD
Voriconazole—Jaundice—Doxorubicin—bone cancer	0.000196	0.000659	CcSEcCtD
Voriconazole—Rhinitis—Epirubicin—bone cancer	0.000196	0.000658	CcSEcCtD
Voriconazole—Urinary tract infection—Doxorubicin—bone cancer	0.000196	0.000657	CcSEcCtD
Voriconazole—Conjunctivitis—Doxorubicin—bone cancer	0.000196	0.000657	CcSEcCtD
Voriconazole—Hepatitis—Epirubicin—bone cancer	0.000195	0.000656	CcSEcCtD
Voriconazole—Eye disorder—Methotrexate—bone cancer	0.000195	0.000655	CcSEcCtD
Voriconazole—Tinnitus—Methotrexate—bone cancer	0.000195	0.000654	CcSEcCtD
Voriconazole—Hypoaesthesia—Epirubicin—bone cancer	0.000194	0.000653	CcSEcCtD
Voriconazole—Asthenia—Cisplatin—bone cancer	0.000194	0.000651	CcSEcCtD
Voriconazole—Pharyngitis—Epirubicin—bone cancer	0.000194	0.000651	CcSEcCtD
Voriconazole—Cardiac disorder—Methotrexate—bone cancer	0.000194	0.000651	CcSEcCtD
Voriconazole—Sweating—Doxorubicin—bone cancer	0.000193	0.000648	CcSEcCtD
Voriconazole—Urinary tract disorder—Epirubicin—bone cancer	0.000193	0.000648	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—JUN—bone cancer	0.000193	0.00324	CbGpPWpGaD
Voriconazole—Oedema peripheral—Epirubicin—bone cancer	0.000193	0.000646	CcSEcCtD
Voriconazole—Haematuria—Doxorubicin—bone cancer	0.000192	0.000645	CcSEcCtD
Voriconazole—Connective tissue disorder—Epirubicin—bone cancer	0.000192	0.000645	CcSEcCtD
Voriconazole—Urethral disorder—Epirubicin—bone cancer	0.000192	0.000643	CcSEcCtD
Voriconazole—Hepatobiliary disease—Doxorubicin—bone cancer	0.000191	0.000639	CcSEcCtD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00019	0.0032	CbGpPWpGaD
Voriconazole—Epistaxis—Doxorubicin—bone cancer	0.00019	0.000638	CcSEcCtD
Voriconazole—Angiopathy—Methotrexate—bone cancer	0.00019	0.000636	CcSEcCtD
Voriconazole—Sinusitis—Doxorubicin—bone cancer	0.000189	0.000634	CcSEcCtD
Voriconazole—Immune system disorder—Methotrexate—bone cancer	0.000189	0.000633	CcSEcCtD
Voriconazole—Visual impairment—Epirubicin—bone cancer	0.000188	0.000632	CcSEcCtD
Voriconazole—Mediastinal disorder—Methotrexate—bone cancer	0.000188	0.000632	CcSEcCtD
Voriconazole—Agranulocytosis—Doxorubicin—bone cancer	0.000188	0.000631	CcSEcCtD
Voriconazole—Chills—Methotrexate—bone cancer	0.000187	0.000629	CcSEcCtD
Voriconazole—Diarrhoea—Cisplatin—bone cancer	0.000185	0.000621	CcSEcCtD
Voriconazole—Erythema multiforme—Epirubicin—bone cancer	0.000185	0.00062	CcSEcCtD
Voriconazole—Alopecia—Methotrexate—bone cancer	0.000185	0.000619	CcSEcCtD
Voriconazole—Bradycardia—Doxorubicin—bone cancer	0.000184	0.000618	CcSEcCtD
Voriconazole—Mental disorder—Methotrexate—bone cancer	0.000183	0.000614	CcSEcCtD
Voriconazole—Eye disorder—Epirubicin—bone cancer	0.000183	0.000613	CcSEcCtD
Voriconazole—Tinnitus—Epirubicin—bone cancer	0.000182	0.000612	CcSEcCtD
Voriconazole—Erythema—Methotrexate—bone cancer	0.000182	0.00061	CcSEcCtD
Voriconazole—Malnutrition—Methotrexate—bone cancer	0.000182	0.00061	CcSEcCtD
Voriconazole—Cardiac disorder—Epirubicin—bone cancer	0.000181	0.000609	CcSEcCtD
Voriconazole—Flushing—Epirubicin—bone cancer	0.000181	0.000609	CcSEcCtD
Voriconazole—Rhinitis—Doxorubicin—bone cancer	0.000181	0.000608	CcSEcCtD
Voriconazole—Hepatitis—Doxorubicin—bone cancer	0.000181	0.000607	CcSEcCtD
Voriconazole—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000181	0.00304	CbGpPWpGaD
Voriconazole—Hypoaesthesia—Doxorubicin—bone cancer	0.00018	0.000604	CcSEcCtD
Voriconazole—Pharyngitis—Doxorubicin—bone cancer	0.00018	0.000602	CcSEcCtD
Voriconazole—Urinary tract disorder—Doxorubicin—bone cancer	0.000179	0.000599	CcSEcCtD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000178	0.003	CbGpPWpGaD
Voriconazole—Oedema peripheral—Doxorubicin—bone cancer	0.000178	0.000598	CcSEcCtD
Voriconazole—Dysgeusia—Methotrexate—bone cancer	0.000178	0.000598	CcSEcCtD
Voriconazole—Connective tissue disorder—Doxorubicin—bone cancer	0.000178	0.000596	CcSEcCtD
Voriconazole—Angiopathy—Epirubicin—bone cancer	0.000177	0.000595	CcSEcCtD
Voriconazole—Urethral disorder—Doxorubicin—bone cancer	0.000177	0.000595	CcSEcCtD
Voriconazole—Immune system disorder—Epirubicin—bone cancer	0.000177	0.000592	CcSEcCtD
Voriconazole—Mediastinal disorder—Epirubicin—bone cancer	0.000176	0.000591	CcSEcCtD
Voriconazole—Back pain—Methotrexate—bone cancer	0.000176	0.00059	CcSEcCtD
Voriconazole—Chills—Epirubicin—bone cancer	0.000175	0.000589	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000175	0.00295	CbGpPWpGaD
Voriconazole—Arrhythmia—Epirubicin—bone cancer	0.000175	0.000586	CcSEcCtD
Voriconazole—Visual impairment—Doxorubicin—bone cancer	0.000174	0.000585	CcSEcCtD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000173	0.00292	CbGpPWpGaD
Voriconazole—Alopecia—Epirubicin—bone cancer	0.000173	0.00058	CcSEcCtD
Voriconazole—Vomiting—Cisplatin—bone cancer	0.000172	0.000577	CcSEcCtD
Voriconazole—Vision blurred—Methotrexate—bone cancer	0.000171	0.000575	CcSEcCtD
Voriconazole—Mental disorder—Epirubicin—bone cancer	0.000171	0.000575	CcSEcCtD
Voriconazole—Erythema multiforme—Doxorubicin—bone cancer	0.000171	0.000574	CcSEcCtD
Voriconazole—Rash—Cisplatin—bone cancer	0.000171	0.000572	CcSEcCtD
Voriconazole—Dermatitis—Cisplatin—bone cancer	0.00017	0.000572	CcSEcCtD
Voriconazole—Malnutrition—Epirubicin—bone cancer	0.00017	0.000571	CcSEcCtD
Voriconazole—Erythema—Epirubicin—bone cancer	0.00017	0.000571	CcSEcCtD
Voriconazole—Eye disorder—Doxorubicin—bone cancer	0.000169	0.000567	CcSEcCtD
Voriconazole—Ill-defined disorder—Methotrexate—bone cancer	0.000169	0.000566	CcSEcCtD
Voriconazole—Tinnitus—Doxorubicin—bone cancer	0.000169	0.000566	CcSEcCtD
Voriconazole—Anaemia—Methotrexate—bone cancer	0.000168	0.000564	CcSEcCtD
Voriconazole—Cardiac disorder—Doxorubicin—bone cancer	0.000168	0.000563	CcSEcCtD
Voriconazole—Flushing—Doxorubicin—bone cancer	0.000168	0.000563	CcSEcCtD
Voriconazole—Flatulence—Epirubicin—bone cancer	0.000168	0.000563	CcSEcCtD
Voriconazole—Dysgeusia—Epirubicin—bone cancer	0.000167	0.000559	CcSEcCtD
Voriconazole—Back pain—Epirubicin—bone cancer	0.000165	0.000552	CcSEcCtD
Voriconazole—Angiopathy—Doxorubicin—bone cancer	0.000164	0.000551	CcSEcCtD
Voriconazole—Malaise—Methotrexate—bone cancer	0.000164	0.00055	CcSEcCtD
Voriconazole—Muscle spasms—Epirubicin—bone cancer	0.000164	0.000549	CcSEcCtD
Voriconazole—Immune system disorder—Doxorubicin—bone cancer	0.000163	0.000548	CcSEcCtD
Voriconazole—Vertigo—Methotrexate—bone cancer	0.000163	0.000548	CcSEcCtD
Voriconazole—Mediastinal disorder—Doxorubicin—bone cancer	0.000163	0.000547	CcSEcCtD
Voriconazole—Leukopenia—Methotrexate—bone cancer	0.000163	0.000546	CcSEcCtD
Voriconazole—Chills—Doxorubicin—bone cancer	0.000162	0.000545	CcSEcCtD
Voriconazole—Arrhythmia—Doxorubicin—bone cancer	0.000162	0.000542	CcSEcCtD
Voriconazole—Nausea—Cisplatin—bone cancer	0.000161	0.000539	CcSEcCtD
Voriconazole—Vision blurred—Epirubicin—bone cancer	0.00016	0.000538	CcSEcCtD
Voriconazole—Alopecia—Doxorubicin—bone cancer	0.00016	0.000536	CcSEcCtD
Voriconazole—Cough—Methotrexate—bone cancer	0.000159	0.000532	CcSEcCtD
Voriconazole—Mental disorder—Doxorubicin—bone cancer	0.000158	0.000532	CcSEcCtD
Voriconazole—Ill-defined disorder—Epirubicin—bone cancer	0.000158	0.00053	CcSEcCtD
Voriconazole—Convulsion—Methotrexate—bone cancer	0.000158	0.000529	CcSEcCtD
Voriconazole—Erythema—Doxorubicin—bone cancer	0.000157	0.000528	CcSEcCtD
Voriconazole—Malnutrition—Doxorubicin—bone cancer	0.000157	0.000528	CcSEcCtD
Voriconazole—Anaemia—Epirubicin—bone cancer	0.000157	0.000528	CcSEcCtD
Voriconazole—Agitation—Epirubicin—bone cancer	0.000156	0.000525	CcSEcCtD
Voriconazole—Flatulence—Doxorubicin—bone cancer	0.000155	0.000521	CcSEcCtD
Voriconazole—Arthralgia—Methotrexate—bone cancer	0.000155	0.000519	CcSEcCtD
Voriconazole—Myalgia—Methotrexate—bone cancer	0.000155	0.000519	CcSEcCtD
Voriconazole—Chest pain—Methotrexate—bone cancer	0.000155	0.000519	CcSEcCtD
Voriconazole—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000155	0.0026	CbGpPWpGaD
Voriconazole—Dysgeusia—Doxorubicin—bone cancer	0.000154	0.000517	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000154	0.000516	CcSEcCtD
Voriconazole—Malaise—Epirubicin—bone cancer	0.000153	0.000515	CcSEcCtD
Voriconazole—Discomfort—Methotrexate—bone cancer	0.000153	0.000513	CcSEcCtD
Voriconazole—Vertigo—Epirubicin—bone cancer	0.000153	0.000513	CcSEcCtD
Voriconazole—Syncope—Epirubicin—bone cancer	0.000153	0.000512	CcSEcCtD
Voriconazole—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000152	0.00256	CbGpPWpGaD
Voriconazole—Leukopenia—Epirubicin—bone cancer	0.000152	0.000511	CcSEcCtD
Voriconazole—Back pain—Doxorubicin—bone cancer	0.000152	0.000511	CcSEcCtD
Voriconazole—Muscle spasms—Doxorubicin—bone cancer	0.000151	0.000508	CcSEcCtD
Voriconazole—Palpitations—Epirubicin—bone cancer	0.00015	0.000505	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—GSTP1—bone cancer	0.00015	0.00252	CbGpPWpGaD
Voriconazole—Confusional state—Methotrexate—bone cancer	0.00015	0.000502	CcSEcCtD
Voriconazole—Loss of consciousness—Epirubicin—bone cancer	0.00015	0.000502	CcSEcCtD
Voriconazole—Cough—Epirubicin—bone cancer	0.000148	0.000498	CcSEcCtD
Voriconazole—Anaphylactic shock—Methotrexate—bone cancer	0.000148	0.000498	CcSEcCtD
Voriconazole—Vision blurred—Doxorubicin—bone cancer	0.000148	0.000498	CcSEcCtD
Voriconazole—Convulsion—Epirubicin—bone cancer	0.000147	0.000495	CcSEcCtD
Voriconazole—Infection—Methotrexate—bone cancer	0.000147	0.000495	CcSEcCtD
Voriconazole—Hypertension—Epirubicin—bone cancer	0.000147	0.000493	CcSEcCtD
Voriconazole—Ill-defined disorder—Doxorubicin—bone cancer	0.000146	0.00049	CcSEcCtD
Voriconazole—Nervous system disorder—Methotrexate—bone cancer	0.000146	0.000488	CcSEcCtD
Voriconazole—Anaemia—Doxorubicin—bone cancer	0.000146	0.000488	CcSEcCtD
Voriconazole—Thrombocytopenia—Methotrexate—bone cancer	0.000145	0.000488	CcSEcCtD
Voriconazole—Chest pain—Epirubicin—bone cancer	0.000145	0.000486	CcSEcCtD
Voriconazole—Arthralgia—Epirubicin—bone cancer	0.000145	0.000486	CcSEcCtD
Voriconazole—Myalgia—Epirubicin—bone cancer	0.000145	0.000486	CcSEcCtD
Voriconazole—Agitation—Doxorubicin—bone cancer	0.000145	0.000486	CcSEcCtD
Voriconazole—Anxiety—Epirubicin—bone cancer	0.000144	0.000484	CcSEcCtD
Voriconazole—Skin disorder—Methotrexate—bone cancer	0.000144	0.000484	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000144	0.000483	CcSEcCtD
Voriconazole—Hyperhidrosis—Methotrexate—bone cancer	0.000143	0.000481	CcSEcCtD
Voriconazole—Discomfort—Epirubicin—bone cancer	0.000143	0.00048	CcSEcCtD
Voriconazole—Malaise—Doxorubicin—bone cancer	0.000142	0.000476	CcSEcCtD
Voriconazole—Dry mouth—Epirubicin—bone cancer	0.000142	0.000475	CcSEcCtD
Voriconazole—Vertigo—Doxorubicin—bone cancer	0.000141	0.000475	CcSEcCtD
Voriconazole—Anorexia—Methotrexate—bone cancer	0.000141	0.000475	CcSEcCtD
Voriconazole—Syncope—Doxorubicin—bone cancer	0.000141	0.000474	CcSEcCtD
Voriconazole—Leukopenia—Doxorubicin—bone cancer	0.000141	0.000473	CcSEcCtD
Voriconazole—Confusional state—Epirubicin—bone cancer	0.00014	0.00047	CcSEcCtD
Voriconazole—Palpitations—Doxorubicin—bone cancer	0.000139	0.000467	CcSEcCtD
Voriconazole—Anaphylactic shock—Epirubicin—bone cancer	0.000139	0.000466	CcSEcCtD
Voriconazole—Oedema—Epirubicin—bone cancer	0.000139	0.000466	CcSEcCtD
Voriconazole—Hypotension—Methotrexate—bone cancer	0.000139	0.000465	CcSEcCtD
Voriconazole—Loss of consciousness—Doxorubicin—bone cancer	0.000138	0.000464	CcSEcCtD
Voriconazole—Infection—Epirubicin—bone cancer	0.000138	0.000463	CcSEcCtD
Voriconazole—Cough—Doxorubicin—bone cancer	0.000137	0.000461	CcSEcCtD
Voriconazole—Shock—Epirubicin—bone cancer	0.000137	0.000458	CcSEcCtD
Voriconazole—Convulsion—Doxorubicin—bone cancer	0.000136	0.000458	CcSEcCtD
Voriconazole—Nervous system disorder—Epirubicin—bone cancer	0.000136	0.000457	CcSEcCtD
Voriconazole—Thrombocytopenia—Epirubicin—bone cancer	0.000136	0.000456	CcSEcCtD
Voriconazole—Hypertension—Doxorubicin—bone cancer	0.000136	0.000456	CcSEcCtD
Voriconazole—FMO1—Metabolism—ENO2—bone cancer	0.000136	0.00229	CbGpPWpGaD
Voriconazole—Tachycardia—Epirubicin—bone cancer	0.000136	0.000455	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000135	0.000454	CcSEcCtD
Voriconazole—Skin disorder—Epirubicin—bone cancer	0.000135	0.000453	CcSEcCtD
Voriconazole—Hyperhidrosis—Epirubicin—bone cancer	0.000134	0.000451	CcSEcCtD
Voriconazole—Insomnia—Methotrexate—bone cancer	0.000134	0.00045	CcSEcCtD
Voriconazole—Myalgia—Doxorubicin—bone cancer	0.000134	0.00045	CcSEcCtD
Voriconazole—Chest pain—Doxorubicin—bone cancer	0.000134	0.00045	CcSEcCtD
Voriconazole—Arthralgia—Doxorubicin—bone cancer	0.000134	0.00045	CcSEcCtD
Voriconazole—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000134	0.00225	CbGpPWpGaD
Voriconazole—Anxiety—Doxorubicin—bone cancer	0.000134	0.000448	CcSEcCtD
Voriconazole—Paraesthesia—Methotrexate—bone cancer	0.000133	0.000447	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000133	0.000447	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000133	0.00223	CbGpPWpGaD
Voriconazole—Discomfort—Doxorubicin—bone cancer	0.000132	0.000444	CcSEcCtD
Voriconazole—Anorexia—Epirubicin—bone cancer	0.000132	0.000444	CcSEcCtD
Voriconazole—Dyspnoea—Methotrexate—bone cancer	0.000132	0.000444	CcSEcCtD
Voriconazole—Somnolence—Methotrexate—bone cancer	0.000132	0.000443	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000132	0.00222	CbGpPWpGaD
Voriconazole—Dry mouth—Doxorubicin—bone cancer	0.000131	0.00044	CcSEcCtD
Voriconazole—Dyspepsia—Methotrexate—bone cancer	0.000131	0.000438	CcSEcCtD
Voriconazole—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000131	0.0022	CbGpPWpGaD
Voriconazole—Hypotension—Epirubicin—bone cancer	0.00013	0.000435	CcSEcCtD
Voriconazole—Confusional state—Doxorubicin—bone cancer	0.00013	0.000435	CcSEcCtD
Voriconazole—Decreased appetite—Methotrexate—bone cancer	0.000129	0.000433	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000129	0.00217	CbGpPWpGaD
Voriconazole—Oedema—Doxorubicin—bone cancer	0.000128	0.000431	CcSEcCtD
Voriconazole—Anaphylactic shock—Doxorubicin—bone cancer	0.000128	0.000431	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Methotrexate—bone cancer	0.000128	0.00043	CcSEcCtD
Voriconazole—Infection—Doxorubicin—bone cancer	0.000128	0.000428	CcSEcCtD
Voriconazole—Pain—Methotrexate—bone cancer	0.000127	0.000426	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000127	0.000425	CcSEcCtD
Voriconazole—Shock—Doxorubicin—bone cancer	0.000126	0.000424	CcSEcCtD
Voriconazole—FMO1—Metabolism—DHFR—bone cancer	0.000126	0.00212	CbGpPWpGaD
Voriconazole—Nervous system disorder—Doxorubicin—bone cancer	0.000126	0.000423	CcSEcCtD
Voriconazole—Thrombocytopenia—Doxorubicin—bone cancer	0.000126	0.000422	CcSEcCtD
Voriconazole—Insomnia—Epirubicin—bone cancer	0.000126	0.000421	CcSEcCtD
Voriconazole—Tachycardia—Doxorubicin—bone cancer	0.000125	0.000421	CcSEcCtD
Voriconazole—Skin disorder—Doxorubicin—bone cancer	0.000125	0.000419	CcSEcCtD
Voriconazole—Paraesthesia—Epirubicin—bone cancer	0.000125	0.000418	CcSEcCtD
Voriconazole—Hyperhidrosis—Doxorubicin—bone cancer	0.000124	0.000417	CcSEcCtD
Voriconazole—Dyspnoea—Epirubicin—bone cancer	0.000124	0.000415	CcSEcCtD
Voriconazole—Somnolence—Epirubicin—bone cancer	0.000123	0.000414	CcSEcCtD
Voriconazole—Anorexia—Doxorubicin—bone cancer	0.000122	0.000411	CcSEcCtD
Voriconazole—Feeling abnormal—Methotrexate—bone cancer	0.000122	0.00041	CcSEcCtD
Voriconazole—Dyspepsia—Epirubicin—bone cancer	0.000122	0.00041	CcSEcCtD
Voriconazole—Gastrointestinal pain—Methotrexate—bone cancer	0.000121	0.000407	CcSEcCtD
Voriconazole—Decreased appetite—Epirubicin—bone cancer	0.000121	0.000405	CcSEcCtD
Voriconazole—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.00012	0.00202	CbGpPWpGaD
Voriconazole—Hypotension—Doxorubicin—bone cancer	0.00012	0.000403	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Epirubicin—bone cancer	0.00012	0.000402	CcSEcCtD
Voriconazole—Constipation—Epirubicin—bone cancer	0.000119	0.000399	CcSEcCtD
Voriconazole—Pain—Epirubicin—bone cancer	0.000119	0.000399	CcSEcCtD
Voriconazole—Urticaria—Methotrexate—bone cancer	0.000118	0.000396	CcSEcCtD
Voriconazole—FMO1—Metabolism—GNA11—bone cancer	0.000118	0.00198	CbGpPWpGaD
Voriconazole—Abdominal pain—Methotrexate—bone cancer	0.000117	0.000394	CcSEcCtD
Voriconazole—Body temperature increased—Methotrexate—bone cancer	0.000117	0.000394	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000117	0.000393	CcSEcCtD
Voriconazole—Insomnia—Doxorubicin—bone cancer	0.000116	0.00039	CcSEcCtD
Voriconazole—Paraesthesia—Doxorubicin—bone cancer	0.000115	0.000387	CcSEcCtD
Voriconazole—Dyspnoea—Doxorubicin—bone cancer	0.000115	0.000384	CcSEcCtD
Voriconazole—Feeling abnormal—Epirubicin—bone cancer	0.000114	0.000384	CcSEcCtD
Voriconazole—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000114	0.00192	CbGpPWpGaD
Voriconazole—Somnolence—Doxorubicin—bone cancer	0.000114	0.000383	CcSEcCtD
Voriconazole—Gastrointestinal pain—Epirubicin—bone cancer	0.000114	0.000381	CcSEcCtD
Voriconazole—Dyspepsia—Doxorubicin—bone cancer	0.000113	0.00038	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000113	0.0019	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000112	0.00188	CbGpPWpGaD
Voriconazole—Decreased appetite—Doxorubicin—bone cancer	0.000112	0.000375	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000111	0.000372	CcSEcCtD
Voriconazole—Urticaria—Epirubicin—bone cancer	0.00011	0.00037	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.00011	0.00185	CbGpPWpGaD
Voriconazole—Pain—Doxorubicin—bone cancer	0.00011	0.000369	CcSEcCtD
Voriconazole—Constipation—Doxorubicin—bone cancer	0.00011	0.000369	CcSEcCtD
Voriconazole—Abdominal pain—Epirubicin—bone cancer	0.00011	0.000368	CcSEcCtD
Voriconazole—Body temperature increased—Epirubicin—bone cancer	0.00011	0.000368	CcSEcCtD
Voriconazole—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.00011	0.00184	CbGpPWpGaD
Voriconazole—Hypersensitivity—Methotrexate—bone cancer	0.000109	0.000367	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—NDUFA12—bone cancer	0.000108	0.00182	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CYP3A4—bone cancer	0.000107	0.0018	CbGpPWpGaD
Voriconazole—Asthenia—Methotrexate—bone cancer	0.000106	0.000357	CcSEcCtD
Voriconazole—Feeling abnormal—Doxorubicin—bone cancer	0.000106	0.000355	CcSEcCtD
Voriconazole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000105	0.000353	CcSEcCtD
Voriconazole—Pruritus—Methotrexate—bone cancer	0.000105	0.000352	CcSEcCtD
Voriconazole—PTGS1—Metabolism—NDUFA12—bone cancer	0.000105	0.00177	CbGpPWpGaD
Voriconazole—Hypersensitivity—Epirubicin—bone cancer	0.000102	0.000343	CcSEcCtD
Voriconazole—Urticaria—Doxorubicin—bone cancer	0.000102	0.000343	CcSEcCtD
Voriconazole—Abdominal pain—Doxorubicin—bone cancer	0.000102	0.000341	CcSEcCtD
Voriconazole—Body temperature increased—Doxorubicin—bone cancer	0.000102	0.000341	CcSEcCtD
Voriconazole—Diarrhoea—Methotrexate—bone cancer	0.000102	0.000341	CcSEcCtD
Voriconazole—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000101	0.0017	CbGpPWpGaD
Voriconazole—Asthenia—Epirubicin—bone cancer	9.96e-05	0.000334	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	9.96e-05	0.00168	CbGpPWpGaD
Voriconazole—Pruritus—Epirubicin—bone cancer	9.83e-05	0.00033	CcSEcCtD
Voriconazole—Dizziness—Methotrexate—bone cancer	9.81e-05	0.000329	CcSEcCtD
Voriconazole—FMO3—Metabolism—ENO2—bone cancer	9.71e-05	0.00163	CbGpPWpGaD
Voriconazole—Diarrhoea—Epirubicin—bone cancer	9.5e-05	0.000319	CcSEcCtD
Voriconazole—Hypersensitivity—Doxorubicin—bone cancer	9.47e-05	0.000318	CcSEcCtD
Voriconazole—Vomiting—Methotrexate—bone cancer	9.44e-05	0.000317	CcSEcCtD
Voriconazole—Rash—Methotrexate—bone cancer	9.36e-05	0.000314	CcSEcCtD
Voriconazole—Dermatitis—Methotrexate—bone cancer	9.35e-05	0.000314	CcSEcCtD
Voriconazole—Headache—Methotrexate—bone cancer	9.3e-05	0.000312	CcSEcCtD
Voriconazole—Asthenia—Doxorubicin—bone cancer	9.22e-05	0.000309	CcSEcCtD
Voriconazole—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.21e-05	0.00155	CbGpPWpGaD
Voriconazole—Dizziness—Epirubicin—bone cancer	9.18e-05	0.000308	CcSEcCtD
Voriconazole—FMO1—Metabolism—GSTP1—bone cancer	9.13e-05	0.00154	CbGpPWpGaD
Voriconazole—Pruritus—Doxorubicin—bone cancer	9.09e-05	0.000305	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.08e-05	0.00153	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—DHFR—bone cancer	9.01e-05	0.00152	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NT5C3A—bone cancer	8.97e-05	0.00151	CbGpPWpGaD
Voriconazole—Vomiting—Epirubicin—bone cancer	8.83e-05	0.000296	CcSEcCtD
Voriconazole—Nausea—Methotrexate—bone cancer	8.81e-05	0.000296	CcSEcCtD
Voriconazole—Diarrhoea—Doxorubicin—bone cancer	8.79e-05	0.000295	CcSEcCtD
Voriconazole—Rash—Epirubicin—bone cancer	8.76e-05	0.000294	CcSEcCtD
Voriconazole—Dermatitis—Epirubicin—bone cancer	8.75e-05	0.000294	CcSEcCtD
Voriconazole—Headache—Epirubicin—bone cancer	8.7e-05	0.000292	CcSEcCtD
Voriconazole—PTGS1—Metabolism—NT5C3A—bone cancer	8.7e-05	0.00146	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.64e-05	0.00145	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.52e-05	0.00143	CbGpPWpGaD
Voriconazole—Dizziness—Doxorubicin—bone cancer	8.5e-05	0.000285	CcSEcCtD
Voriconazole—FMO3—Metabolism—GNA11—bone cancer	8.42e-05	0.00142	CbGpPWpGaD
Voriconazole—Nausea—Epirubicin—bone cancer	8.25e-05	0.000277	CcSEcCtD
Voriconazole—Vomiting—Doxorubicin—bone cancer	8.17e-05	0.000274	CcSEcCtD
Voriconazole—Rash—Doxorubicin—bone cancer	8.1e-05	0.000272	CcSEcCtD
Voriconazole—Dermatitis—Doxorubicin—bone cancer	8.09e-05	0.000272	CcSEcCtD
Voriconazole—Headache—Doxorubicin—bone cancer	8.05e-05	0.00027	CcSEcCtD
Voriconazole—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.02e-05	0.00135	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—NDUFA12—bone cancer	8.01e-05	0.00135	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.87e-05	0.00132	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NDUFA12—bone cancer	7.83e-05	0.00132	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.77e-05	0.00131	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CYP3A4—bone cancer	7.63e-05	0.00128	CbGpPWpGaD
Voriconazole—Nausea—Doxorubicin—bone cancer	7.63e-05	0.000256	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—NT5C3A—bone cancer	6.64e-05	0.00112	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GSTP1—bone cancer	6.53e-05	0.0011	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NT5C3A—bone cancer	6.49e-05	0.00109	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NDUFA12—bone cancer	6.05e-05	0.00102	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NDUFA12—bone cancer	5.52e-05	0.000929	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.19e-05	0.000874	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.12e-05	0.000862	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NT5C3A—bone cancer	5.02e-05	0.000844	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTGS2—bone cancer	4.73e-05	0.000796	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NT5C3A—bone cancer	4.57e-05	0.000769	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—ENO2—bone cancer	3.93e-05	0.000661	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—ENO2—bone cancer	3.81e-05	0.000641	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—DHFR—bone cancer	3.65e-05	0.000614	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NDUFA12—bone cancer	3.64e-05	0.000612	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—DHFR—bone cancer	3.54e-05	0.000595	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GNA11—bone cancer	3.41e-05	0.000573	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTGS2—bone cancer	3.38e-05	0.000569	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GNA11—bone cancer	3.3e-05	0.000556	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CYP3A4—bone cancer	3.09e-05	0.00052	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NT5C3A—bone cancer	3.02e-05	0.000507	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP3A4—bone cancer	3e-05	0.000504	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.98e-05	0.000501	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—ENO2—bone cancer	2.91e-05	0.000489	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—ENO2—bone cancer	2.84e-05	0.000478	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—DHFR—bone cancer	2.7e-05	0.000454	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GSTP1—bone cancer	2.64e-05	0.000445	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—DHFR—bone cancer	2.64e-05	0.000444	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GSTP1—bone cancer	2.56e-05	0.000431	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GNA11—bone cancer	2.52e-05	0.000424	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GNA11—bone cancer	2.46e-05	0.000415	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP3A4—bone cancer	2.29e-05	0.000385	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP3A4—bone cancer	2.23e-05	0.000376	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—ENO2—bone cancer	2.2e-05	0.00037	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—DHFR—bone cancer	2.04e-05	0.000343	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—ENO2—bone cancer	2e-05	0.000337	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GSTP1—bone cancer	1.95e-05	0.000329	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GSTP1—bone cancer	1.91e-05	0.000321	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GNA11—bone cancer	1.9e-05	0.00032	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—DHFR—bone cancer	1.86e-05	0.000313	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GNA11—bone cancer	1.74e-05	0.000292	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP3A4—bone cancer	1.73e-05	0.000291	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.72e-05	0.000289	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP3A4—bone cancer	1.57e-05	0.000265	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.57e-05	0.000264	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GSTP1—bone cancer	1.48e-05	0.000249	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTGS2—bone cancer	1.37e-05	0.00023	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GSTP1—bone cancer	1.35e-05	0.000227	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTGS2—bone cancer	1.33e-05	0.000223	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—ENO2—bone cancer	1.32e-05	0.000222	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—DHFR—bone cancer	1.23e-05	0.000206	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GNA11—bone cancer	1.15e-05	0.000193	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTGS2—bone cancer	1.01e-05	0.00017	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTGS2—bone cancer	9.9e-06	0.000167	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GSTP1—bone cancer	8.88e-06	0.000149	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTGS2—bone cancer	7.65e-06	0.000129	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTGS2—bone cancer	6.98e-06	0.000117	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTGS2—bone cancer	4.6e-06	7.74e-05	CbGpPWpGaD
